Meng Xu

8.7k total citations · 5 hit papers
92 papers, 6.0k citations indexed

About

Meng Xu is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Meng Xu has authored 92 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 69 papers in Molecular Biology, 29 papers in Cancer Research and 13 papers in Immunology. Recurrent topics in Meng Xu's work include RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (17 papers) and Cancer-related gene regulation (11 papers). Meng Xu is often cited by papers focused on RNA modifications and cancer (21 papers), Cancer-related molecular mechanisms research (17 papers) and Cancer-related gene regulation (11 papers). Meng Xu collaborates with scholars based in China, United States and Germany. Meng Xu's co-authors include Ralph R. Weichselbaum, Dali Han, Xiaona Huang, Hua Liang, Liufu Deng, Yang‐Xin Fu, Xiao-Dong Li, Zhijian J. Chen, Ainhoa Arina and Helena J. Mauceri and has published in prestigious journals such as Nature, Science and Advanced Materials.

In The Last Decade

Meng Xu

88 papers receiving 6.0k citations

Hit Papers

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-... 2014 2026 2018 2022 2014 2019 2020 2021 2021 500 1000 1.5k

Peers

Meng Xu
Helena J. Mauceri United States
Kimberly R. Kalli United States
Karen E. Pollok United States
Christine Feig United Kingdom
Meng Xu
Citations per year, relative to Meng Xu Meng Xu (= 1×) peers Luana Lugini

Countries citing papers authored by Meng Xu

Since Specialization
Citations

This map shows the geographic impact of Meng Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng Xu more than expected).

Fields of papers citing papers by Meng Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng Xu. The network helps show where Meng Xu may publish in the future.

Co-authorship network of co-authors of Meng Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Meng Xu. A scholar is included among the top collaborators of Meng Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng Xu. Meng Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Yi, Jing Yang, Bryan E. Snow, et al.. (2025). LARP4-mediated hypertranslation drives T cell dysfunction in tumors. Nature Immunology. 26(9). 1488–1500. 2 indexed citations
2.
Xu, Meng, et al.. (2024). Ursolic Acid Inhibits Glycolysis of Ovarian Cancer via KLF5/PI3K/AKT Signaling Pathway. The American Journal of Chinese Medicine. 52(7). 2211–2231. 1 indexed citations
3.
Huang, Xianpeng, et al.. (2024). Construction of Lentiviral Vectors Carrying Six Pluripotency Genes in Yak to Obtain Yak iPSC Cells. International Journal of Molecular Sciences. 25(17). 9431–9431.
4.
Wang, Yu, Zhengpeng Wan, Xiangjun Chen, et al.. (2024). Progressive polyadenylation and m6A modification of Ighg1 mRNA maintain IgG1 antibody homeostasis in antibody-secreting cells. Immunity. 57(11). 2547–2564.e12. 9 indexed citations
5.
Zhou, Yi, Shu Zhang, Xue Wang, et al.. (2024). TSC/mTORC1 mediates mTORC2/AKT1 signaling in c-MYC–induced murine hepatocarcinogenesis via centromere protein M. Journal of Clinical Investigation. 134(22). 3 indexed citations
6.
You, Menghao, Jingjing Liu, Wenhui Guo, et al.. (2023). Mettl3-m6A-Creb1 forms an intrinsic regulatory axis in maintaining iNKT cell pool and functional differentiation. Cell Reports. 42(6). 112584–112584. 9 indexed citations
7.
Tao, Jinsong, Yaxin Cheng, Meng Xu, et al.. (2022). Apoptosis-Sensing Xenograft Zebrafish Tumor Model for Anticancer Evaluation of Redox-Responsive Cross-Linked Pluronic Micelles. ACS Applied Materials & Interfaces. 14(35). 39775–39786. 7 indexed citations
8.
Hoefig, Kai P., Gesine Behrens, Meng Xu, et al.. (2021). Defining the RBPome of primary T helper cells to elucidate higher-order Roquin-mediated mRNA regulation. Nature Communications. 12(1). 5208–5208. 26 indexed citations
9.
Ma, Shanshan, et al.. (2020). Rosmarinic Acid Prevents Radiation-Induced Pulmonary Fibrosis Through Attenuation of ROS/MYPT1/TGFβ1 Signaling Via miR-19b-3p. Dose-Response. 18(4). 3584417245–3584417245. 21 indexed citations
10.
Xu, Meng, Haichuan Wang, Jingxiao Wang, et al.. (2020). mTORC2 Signaling Is Necessary for Timely Liver Regeneration after Partial Hepatectomy. American Journal Of Pathology. 190(4). 817–829. 14 indexed citations
11.
Xu, Meng, Yue Li, Jun Zhou, et al.. (2020). Identifying Long Non-coding RNA of Prostate Cancer Associated With Radioresponse by Comprehensive Bioinformatics Analysis. Frontiers in Oncology. 10. 498–498. 9 indexed citations
12.
Liu, Xianqiong, Junjie Hu, Xinhua Song, et al.. (2019). Combined Treatment with MEK and mTOR Inhibitors is Effective in In Vitro and In Vivo Models of Hepatocellular Carcinoma. Cancers. 11(7). 930–930. 11 indexed citations
13.
Wang, Jingxiao, Haichuan Wang, Ning Ding, et al.. (2019). Loss of Fbxw7 synergizes with activated Akt signaling to promote c-Myc dependent cholangiocarcinogenesis. Journal of Hepatology. 71(4). 742–752. 47 indexed citations
14.
15.
Xu, Zhong, Junjie Hu, Hui Cao, et al.. (2018). Loss of Pten synergizes with c-Met to promote hepatocellular carcinoma development via mTORC2 pathway. Experimental & Molecular Medicine. 50(1). e417–e417. 42 indexed citations
16.
Xu, Meng, Pu Yang, Dali Han, et al.. (2017). Dendritic Cells but Not Macrophages Sense Tumor Mitochondrial DNA for Cross-priming through Signal Regulatory Protein α Signaling. Immunity. 47(2). 363–373.e5. 241 indexed citations
17.
Xu, Meng, Qingquan Liu, Yuli Jia, et al.. (2016). BCAT1 promotes tumor cell migration and invasion in hepatocellular carcinoma. Oncology Letters. 12(4). 2648–2656. 33 indexed citations
18.
Han, Dali, Xingyu Lu, Alan H. Shih, et al.. (2016). A Highly Sensitive and Robust Method for Genome-wide 5hmC Profiling of Rare Cell Populations. Molecular Cell. 63(4). 711–719. 120 indexed citations
19.
Jia, Yuli, Meng Xu, Changwei Dou, et al.. (2016). P300/CBP-associated factor (PCAF) inhibits the growth of hepatocellular carcinoma by promoting cell autophagy. Cell Death and Disease. 7(10). e2400–e2400. 37 indexed citations
20.
Deng, Liufu, Hua Liang, Meng Xu, et al.. (2014). STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors. Immunity. 41(5). 843–852. 1538 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026